The global respiratory disease testing market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of respiratory diseases and increasing awareness about the importance of early diagnosis and treatment.
The imaging test segment accounted for the largest share in 2018, followed by respiratory measurement and blood gas test segments. Imaging tests are used for diagnosing various types of lung diseases such as asthma, chronic obstructive pulmonary disease (COPD), bronchitis, pneumonia, tuberculosis (TB), lung cancer etc, which are major contributors to this segment’s growth. Respiratory measurement tests are used for measuring lung function such as forced expiratory volume in 1 second (FEV1) or peak expiratory flow rate (PEFR). Blood gas tests measure oxygen levels in blood and carbon dioxide levels in blood which can be used for diagnosing various types of respiratory diseases such as asthma or COPD.
- The global respiratory disease testing market is expected to grow at a CAGR of 5.5% from 2017 to 2022.
- The increasing prevalence of respiratory diseases such as asthma and COPD is one of the major factors driving the growth of the global respiratory disease testing market over the forecast period.
- Rising awareness about lung cancer and other lung-related diseases among people has led to an increase in demand for diagnostic tests for these conditions, which in turn is expected to drive growth in this market over the next few years.
- Increasing incidence rates of chronic obstructive pulmonary disease (COPD) are also expected to fuel demand for diagnostic tests for this condition over the forecast period, thereby boosting growth prospects for this market segment during 2017-2022.
Industry Growth Insights published a new data on “Respiratory Disease Testing Market”. The research report is titled “Respiratory Disease Testing Market research by Types (Imaging test, Respiratory Measurement, Blood gas test, Other), By Applications (Hospitals, Physician clinics, Clinical laboratories, Others), By Players/Companies Fischer & Paykel, Medtronic, MGC Diagnostics Corporation, CAREstream Medical Ltd., Becton Dickinson (Carefusion Corporation), Koninklijke Philips N.V. (Respironics), ResMed Company”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Respiratory Disease Testing Market Research Report
By Type
Imaging test, Respiratory Measurement, Blood gas test, Other
By Application
Hospitals, Physician clinics, Clinical laboratories, Others
By Companies
Fischer & Paykel, Medtronic, MGC Diagnostics Corporation, CAREstream Medical Ltd., Becton Dickinson (Carefusion Corporation), Koninklijke Philips N.V. (Respironics), ResMed Company
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Respiratory Disease Testing Market Report Segments:
The global Respiratory Disease Testing market is segmented on the basis of:
Types
Imaging test, Respiratory Measurement, Blood gas test, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Physician clinics, Clinical laboratories, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Fischer & Paykel
- Medtronic
- MGC Diagnostics Corporation
- CAREstream Medical Ltd.
- Becton Dickinson (Carefusion Corporation)
- Koninklijke Philips N.V. (Respironics)
- ResMed Company
Highlights of The Respiratory Disease Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Imaging test
- Respiratory Measurement
- Blood gas test
- Other
- By Application:
- Hospitals
- Physician clinics
- Clinical laboratories
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Respiratory Disease Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Respiratory disease testing is a process by which a doctor can determine if you have an infection in your lungs. This can include tests for bacteria, viruses, and fungi.
Some of the major players in the respiratory disease testing market are Fischer & Paykel, Medtronic, MGC Diagnostics Corporation, CAREstream Medical Ltd., Becton Dickinson (Carefusion Corporation), Koninklijke Philips N.V. (Respironics), ResMed Company.
The respiratory disease testing market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Respiratory Disease Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Respiratory Disease Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Respiratory Disease Testing Market - Supply Chain
4.5. Global Respiratory Disease Testing Market Forecast
4.5.1. Respiratory Disease Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Respiratory Disease Testing Market Size (000 Units) and Y-o-Y Growth
4.5.3. Respiratory Disease Testing Market Absolute $ Opportunity
5. Global Respiratory Disease Testing Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Respiratory Disease Testing Market Size and Volume Forecast by Type
5.3.1. Imaging test
5.3.2. Respiratory Measurement
5.3.3. Blood gas test
5.3.4. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Respiratory Disease Testing Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Respiratory Disease Testing Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Physician clinics
6.3.3. Clinical laboratories
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Respiratory Disease Testing Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Respiratory Disease Testing Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Respiratory Disease Testing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Respiratory Disease Testing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Respiratory Disease Testing Demand Share Forecast, 2019-2026
9. North America Respiratory Disease Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Respiratory Disease Testing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Respiratory Disease Testing Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Physician clinics
9.4.3. Clinical laboratories
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Respiratory Disease Testing Market Size and Volume Forecast by Type
9.7.1. Imaging test
9.7.2. Respiratory Measurement
9.7.3. Blood gas test
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Respiratory Disease Testing Demand Share Forecast, 2019-2026
10. Latin America Respiratory Disease Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Respiratory Disease Testing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Respiratory Disease Testing Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Physician clinics
10.4.3. Clinical laboratories
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Respiratory Disease Testing Market Size and Volume Forecast by Type
10.7.1. Imaging test
10.7.2. Respiratory Measurement
10.7.3. Blood gas test
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Respiratory Disease Testing Demand Share Forecast, 2019-2026
11. Europe Respiratory Disease Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Respiratory Disease Testing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Respiratory Disease Testing Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Physician clinics
11.4.3. Clinical laboratories
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Respiratory Disease Testing Market Size and Volume Forecast by Type
11.7.1. Imaging test
11.7.2. Respiratory Measurement
11.7.3. Blood gas test
11.7.4. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Respiratory Disease Testing Demand Share, 2019-2026
12. Asia Pacific Respiratory Disease Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Respiratory Disease Testing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Respiratory Disease Testing Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Physician clinics
12.4.3. Clinical laboratories
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Respiratory Disease Testing Market Size and Volume Forecast by Type
12.7.1. Imaging test
12.7.2. Respiratory Measurement
12.7.3. Blood gas test
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Respiratory Disease Testing Demand Share, 2019-2026
13. Middle East & Africa Respiratory Disease Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Respiratory Disease Testing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Respiratory Disease Testing Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Physician clinics
13.4.3. Clinical laboratories
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Respiratory Disease Testing Market Size and Volume Forecast by Type
13.7.1. Imaging test
13.7.2. Respiratory Measurement
13.7.3. Blood gas test
13.7.4. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Respiratory Disease Testing Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Respiratory Disease Testing Market: Market Share Analysis
14.2. Respiratory Disease Testing Distributors and Customers
14.3. Respiratory Disease Testing Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Fischer & Paykel
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Medtronic
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. MGC Diagnostics Corporation
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. CAREstream Medical Ltd.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Becton Dickinson (Carefusion Corporation)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Koninklijke Philips N.V. (Respironics)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. ResMed Company
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
